Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1373935
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1373935
Bioengineered Protein Drugs Market, by Drugs Type, by Diseases, by Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 289 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Bioengineered Protein Drugs Market size was valued at USD 3,54,100.22 Million in 2022, expanding at a CAGR of 8.01% from 2023 to 2030.
Bioengineered protein therapeutics encompass medically valuable compounds generated through genetic engineering methodologies, often leveraging living organisms such as mammalian cells or bacteria to produce proteins with distinct therapeutic attributes. These medications emulate or enhance the functions of naturally occurring proteins within the body and are employed for the treatment of various medical conditions, including diabetes, cancer, and autoimmune disorders.
These therapeutics hold a significant place in the field of medicine due to their precision in targeting specific biological processes, their potential to minimize adverse effects, and their promise in improving the health and overall well-being of patients.
Bioengineered Protein Drugs Market- Market Dynamics
Increasing prevalence of complex and challenging-to-treat diseases to propel market demand
The demand for medications derived from bioengineered proteins is significantly propelled by the increasing prevalence of complex and challenging-to-treat diseases. Conditions such as autoimmune disorders, cancer, and rare genetic ailments often necessitate highly targeted and personalized treatments. Bioengineered protein therapeutics, such as enzyme replacements and monoclonal antibodies, exemplify precise and potent solutions for managing these disorders.
Furthermore, advancements in biotechnology and genetic engineering have made it possible to produce these therapeutics more efficiently, leading to reduced production costs and improved accessibility. Consequently, there is a growing demand for bioengineered protein therapeutics owing to their potential to enhance patient outcomes and quality of life, coupled with an enhanced understanding of the underlying causes of diseases and the promise of tailored treatments.
Bioengineered Protein Drugs Market- Key Insights
According to the analysis provided by our research analyst, the global market for Bioengineered Protein Drugs is expected to witness an annual growth rate of approximately 8.01% over the forecast period spanning from 2023 to 2030.
The Bioengineered Protein Drugs industry is poised for significant growth, primarily driven by the increasing prevalence of complex and challenging-to-treat diseases.
In terms of drug type segmentation, the year 2022 saw Therapeutic enzymes as the leading category in the market.
Regarding disease segmentation, Diabetes emerged as the dominant segment in 2022.
In terms of technology segmentation, Pharming was the leading category in 2022.
Finally, with respect to regions, North America stood out as the leading revenue generator in 2022.
Bioengineered Protein Drugs Market- Segmentation Analysis:
The Global Bioengineered Protein Drugs Market is segmented based on Drug Type, Disease, Technology, and Region.
In terms of Drug Type, the market encompasses a range of categories including Peptide hormones, Recombinant protein drugs, Therapeutic enzymes, Vaccines, Cytokines, Monoclonal antibodies, Peptide antibiotics, Replacement proteins, and Others. Notably, therapeutic enzymes are expected to lead the bioengineered protein drug industry due to their versatility in treating various medical conditions and their potential applicability in personalized medicine.
Bioengineered Protein Drugs Market- Geographical Insights
This market spans across various geographical regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented according to the countries contributing to the market.
North America is anticipated to dominate the market, primarily due to significant technological advancements and extensive research and development efforts in the field of bioengineered protein therapeutics, which have contributed to its leadership position in the industry.
Bioengineered Protein Drugs Market- Competitive Landscape:
Companies distribute their products through a variety of channels, which encompass corporate websites, e-commerce platforms, retail outlets, distribution partners, and direct-to-consumer sales. These product manufacturers engage in competition across several dimensions, including pricing, product performance, manufacturing capabilities, distribution channels, brand reputation, and product availability.
To enhance their market presence and expand their market share, businesses employ various strategies. These strategies encompass launching new products, expanding their distribution networks, investing in research and development, and engaging in mergers and acquisitions. As an example, in April 2022, Satellite Bio introduced an innovative approach to tissue engineering. This company specializes in regenerative medicine, synthetic biology, cell biology, cell therapy, and tissue engineering.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET KEY PLAYERS
- Vertex Pharmaceuticals
- Sanofi
- Regeneron Pharmaceuticals
- Pfizer
- Novo Nordisk
- Merck & Co.
- Johnson & Johnson (Janssen Pharmaceuticals)
- Gilead Sciences
- Genentech (Roche)
- Eli Lilly and Company
- Bristol-Myers Squibb
- Biogen
- AstraZeneca
- Amgen
- AbbVie
GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY DRUG TYPE
- Peptide hormones
- Recombinant protein drugs
- Therapeutic enzymes
- Vaccines
- Cytokines
- Monoclonal antibodies
- Peptide antibiotics
- Replacement proteins
- Others
GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY DISEASES
- Cancer
- Diabetes
- Blood disorders
- Skin diseases
- Neurodegenerative diseases
- Heart diseases
- Infectious diseases
- Respiratory diseases
- Others
GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY TECHNOLOGY
- Bioreactors and Microbial Cell Fermentation
- Fractionation
- Genetically Modified Organisms
- Genetic Engineering
- Pharming
- Others
GLOBAL BIOENGINEERED PROTEIN DRUGS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1810
Table of Contents
1. Bioengineered Protein Drugs Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Bioengineered Protein Drugs Market Snippet by Drug Type
- 2.1.2. Bioengineered Protein Drugs Market Snippet by Diseases
- 2.1.3. Bioengineered Protein Drugs Market Snippet by Technology
- 2.1.4. Bioengineered Protein Drugs Market Snippet by Country
- 2.1.5. Bioengineered Protein Drugs Market Snippet by Region
- 2.2. Competitive Insights
3. Bioengineered Protein Drugs Key Market Trends
- 3.1. Bioengineered Protein Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Bioengineered Protein Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Bioengineered Protein Drugs Market Opportunities
- 3.4. Bioengineered Protein Drugs Market Future Trends
4. Bioengineered Protein Drugs Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Bioengineered Protein Drugs Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Bioengineered Protein Drugs Market Landscape
- 6.1. Bioengineered Protein Drugs Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Bioengineered Protein Drugs Market - By Drug Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
- 7.1.2. Peptide hormones
- 7.1.3. Recombinant protein drugs
- 7.1.4. Therapeutic enzymes
- 7.1.5. Vaccines
- 7.1.6. Cytokines
- 7.1.7. Monoclonal antibodies
- 7.1.8. Peptide antibiotics
- 7.1.9. Replacement proteins
- 7.1.10. Others
8. Bioengineered Protein Drugs Market - By Diseases
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Diseases, 2022 & 2030 (%)
- 8.1.2. Cancer
- 8.1.3. Diabetes
- 8.1.4. Blood disorders
- 8.1.5. Skin diseases
- 8.1.6. Neurodegenerative diseases
- 8.1.7. Heart diseases
- 8.1.8. Infectious diseases
- 8.1.9. Respiratory diseases
- 8.1.10. Others
9. Bioengineered Protein Drugs Market - By Technology
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
- 9.1.2. Bioreactors and Microbial Cell Fermentation
- 9.1.3. Fractionation
- 9.1.4. Genetically Modified Organisms
- 9.1.5. Genetic Engineering
- 9.1.6. Pharming
- 9.1.7. Others
10. Bioengineered Protein Drugs Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Bioengineered Protein Drugs Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Bioengineered Protein Drugs Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Bioengineered Protein Drugs Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Bioengineered Protein Drugs Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Bioengineered Protein Drugs Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Bioengineered Protein Drugs Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Vertex Pharmaceuticals
- 11.2.2. Sanofi
- 11.2.3. Regeneron Pharmaceuticals
- 11.2.4. Pfizer
- 11.2.5. Novo Nordisk
- 11.2.6. Merck & Co.
- 11.2.7. Johnson & Johnson (Janssen Pharmaceuticals)
- 11.2.8. Gilead Sciences
- 11.2.9. Genentech (Roche)
- 11.2.10. Eli Lilly and Company
- 11.2.11. Bristol-Myers Squibb
- 11.2.12. Biogen
- 11.2.13. AstraZeneca
- 11.2.14. Amgen
- 11.2.15. AbbVie
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV1810
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Bioengineered Protein Drugs Market: Drug Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Drug Type
- TABLE Global Bioengineered Protein Drugs Market, by Drug Type 2018-2030 (USD Million)
- TABLE Bioengineered Protein Drugs Market: Diseases Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Diseases
- TABLE Global Bioengineered Protein Drugs Market, by Diseases 2018-2030 (USD Million)
- TABLE Bioengineered Protein Drugs Market: Technology Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Technology
- TABLE Global Bioengineered Protein Drugs Market, by Technology 2018-2030 (USD Million)
- TABLE Bioengineered Protein Drugs Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Bioengineered Protein Drugs Market, by Region 2018-2030 (USD Million)
- TABLE North America Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE North America Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
- TABLE North America Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
- TABLE North America Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
- TABLE Europe Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
- TABLE Europe Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
- TABLE Europe Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
- TABLE Asia Pacific Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
- TABLE Asia Pacific Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
- TABLE Latin America Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
- TABLE Latin America Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
- TABLE Latin America Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
- TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Drug Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Diseases, 2018-2030 (USD Million)
- TABLE Middle East and Africa Bioengineered Protein Drugs Market, by Technology, 2018-2030 (USD Million)
List of Figures
- FIGURE Bioengineered Protein Drugs Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2022
- FIGURE Drug Type segment market share analysis, 2022 & 2030
- FIGURE Drug Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Diseases segment market share analysis, 2022 & 2030
- FIGURE Diseases segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Technology segment market share analysis, 2022 & 2030
- FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Regional segment market share analysis, 2022 & 2030
- FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE North America Bioengineered Protein Drugs Market share and leading players, 2022
- FIGURE Europe Bioengineered Protein Drugs Market share and leading players, 2022
- FIGURE Asia Pacific Bioengineered Protein Drugs Market share and leading players, 2022
- FIGURE Latin America Bioengineered Protein Drugs Market share and leading players, 2022
- FIGURE Middle East and Africa Bioengineered Protein Drugs Market share and leading players, 2022
- FIGURE North America market share analysis by country, 2022
- FIGURE U.S. Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Canada Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Europe Bioengineered Protein Drugs Market share analysis by country, 2022
- FIGURE Germany Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Spain Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Italy Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE France Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE UK Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Russia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Netherlands Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Sweden Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Poland Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of the Europe Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Asia Pacific Bioengineered Protein Drugs Market share analysis by country, 2022
- FIGURE India Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE China Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Japan Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE South Korea Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Australia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Thailand Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Indonesia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Phillipines Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of APAC Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Bioengineered Protein Drugs Market share analysis by country, 2022
- FIGURE Brazil Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Mexico Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Argentina Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Colombia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of LATAM Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Bioengineered Protein Drugs Market share analysis by country, 2022
- FIGURE Saudi Arabia Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE United Arab Emirates Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Israel Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Turkey Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Algeria Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Egypt Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of MEA Bioengineered Protein Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.